KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 123 filers reported holding KEROS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,581 | -73.5% | 8,958 | -66.6% | 0.00% | -75.0% |
| Q2 2023 | $1,078,351 | -32.9% | 26,838 | -28.6% | 0.00% | -42.9% |
| Q1 2023 | $1,605,990 | +157.7% | 37,611 | +189.8% | 0.01% | +133.3% |
| Q4 2022 | $623,300 | -24.7% | 12,980 | -41.0% | 0.00% | -40.0% |
| Q3 2022 | $828,000 | -44.5% | 22,016 | -59.3% | 0.01% | -54.5% |
| Q2 2022 | $1,493,000 | – | 54,031 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 276,000 | $7,626,000 | 3.44% |
| First Light Asset Management, LLC | 598,333 | $16,532,000 | 1.92% |
| Fairmount Funds Management LLC | 272,498 | $7,529,000 | 1.72% |
| Deep Track Capital, LP | 739,528 | $20,433,000 | 1.34% |
| Nantahala Capital Management | 911,901 | $25,196,000 | 1.26% |
| Octagon Capital Advisors LP | 152,249 | $4,207,000 | 1.12% |
| CHI Advisors LLC | 103,429 | $2,858,000 | 1.09% |
| Altium Capital Management LP | 88,000 | $2,431,000 | 0.97% |
| Orbimed Advisors | 1,679,417 | $46,402,000 | 0.84% |
| Parkman Healthcare Partners LLC | 47,788 | $1,320,000 | 0.49% |